Biology subjects

Dou, R.

Publications and source records attributed to Dou, R..

8 recordsLinked to original sources

bioRxiv2026

KRAS-driven metabolic reprogramming of enhanced MFSD2A-mediated lysophosphatidylcholine scavenging promotes survival and progression of pancreatic ductal adenocarcinoma

Oncogenic KRAS drives lipid reprogramming in pancreatic ductal adenocarcinoma (PDAC) to promote disease progression, and these changes are manifest in circulation. Using mass spectrometry, we performed lipidomic analyses on plasmas from a cohort of 93 newly-diagnosed resectable PDAC cases, 43 patients with chronic pancreatitis, and 93 age- and sex-matched healthy controls, the results of which revealed pronounced reductions in circulating lysophosphatidylcholines (LysoPC) as a prominent feature associated with PDAC. Using stable-isotope resolved lipidomics, we further found that PDAC cells exhibit a lipid scavenging phenotype characterized by preferential uptake of extracellular unsaturated LysoPCs to sustain pro-growth signals. Restricting bioavailability of extracellular unsaturated LysoPCs shifted the metabolic phenotype of PDAC cells towards enhanced de novo lipogenesis and autophagy, which was accompanied by suppression of AKT signaling activities and increased susceptibility to apoptosis. Using bulk, single-cell, and spatial transcriptomic datasets together with functional experiments, we identified oncogenic KRAS-mediated upregulation of major facilitator superfamily domain-containing protein 2a (MFSD2A) as a key mediator that facilitates extracellular uptake of LysoPCs in PDAC cells. Loss of MFSD2A expression mimicked LysoPC restriction and resulted in inhibition of AKT signaling and increased propensity of PDAC cells to undergo apoptosis in vitro and suppressed tumor growth in vivo. Therapeutic targeting of the KRAS-MFSD2A-LysoPC axis via repurposing of the synthetic alkyl-lysophospholipid edelfosine promoted potent anti-cancer effects in vitro that were mechanistically attributed to reduced extracellular uptake of LysoPCs, and attenuation of AKT signaling. Collectively, our findings describe a previously unrecognized onco-metabolic program of enhanced LysoPC scavenging mediated by MFSD2A that promotes PDAC progression and that is therapeutically targetable via repurposing edelfosine.

cancer biology↗

bioRxiv2026

Dissociable Anterior and Posterior Beta-Burst Dynamics Track Thought Disorder in Schizophrenia

BackgroundThought disorder in schizophrenia reflects disrupted internal model maintenance in predictive processing. Beta oscillations have been proposed to index top-down predictive signalling, but prior resting-state studies have focused on spectral power, overlooking transient burst dynamics that enable the stabilization and reinstatement of internal representations, especially in the default mode network (DMN). MethodsResting-state MEG was acquired from 25 patients (7 females) with schizophrenia and 25 matched controls (8 females) between May 2024 and October 2025. Beta bursts (15-30 Hz) were extracted from source-localized cortical time series, and burst rate, duration, power, and inter-regional synchrony were quantified. Associations with computationally-derived semantic and syntactic speech features were assessed using principal-component regression within patients. ResultsConventional beta power did not differ between groups after correction. In contrast, beta-burst dynamics showed significant group-by-anterior-posterior-position interactions for burst rate (p = 0.018), power (p = 0.0014) and duration (p < 0.001). Within the DMN, patients showed shorter inferior parietal burst duration (t(46.0) = -2.74, FDR-p = 0.0343) and increased burst synchrony within left prefrontal cortex (t(31.0) = 2.81, FDR-p = 0.0343) and between prefrontal cortices (t(29.8) = 2.73, FDR-p = 0.0423). Within patients, burst components predicted speech organization (R{superscript 2} = 0.47, F(3,19) = 5.66, p = 0.006), driven by the inferior parietal burst-duration component ({beta} = -0.55, p = 0.0036), but did not predict overall clinical severity. LimitationsThe modest patient sample, short resting-state recording, cross-sectional design, and lack of laminar specificity limit causal and mechanistic inference; burst-speech associations require replication. ConclusionSchizophrenia was associated with dissociable anterior and posterior beta-burst abnormalities that tracked objective speech markers of thought disorder. These findings suggest impaired hierarchical coordination of predictive beta signalling as a candidate mechanism linking intrinsic network dysfunction to disorganized thought.

neuroscience↗

bioRxiv2026

Distributed neurophysiological dynamics link perception, action, and language in schizophrenia

Schizophrenia is characterized by disturbances in both perception and expression that profoundly impair social functioning, yet these domains are typically studied in isolation. Predictive processing theories suggest that such symptoms may arise from abnormal updating of internal models, but the neural mechanisms linking perceptual and expressive dysfunction remain unclear. Using magnetoencephalography during multisensory perception and motor tasks, we tested whether beta-band activity (15-30 Hz), a neural signal implicated in predictive control, provides a shared substrate across domains. Compared to healthy individuals, patients with schizophrenia showed attenuated event-related modulation of beta activity, including weaker beta suppression during sensory processing and delayed or reduced post-movement beta rebound. These abnormalities were associated with a widened audiovisual temporal binding window, indicating atypical multisensory integration. Multivariate analyses further revealed that reduced beta modulation across sensory and motor systems covaried with impoverished semantic diversity, simplified syntactic structure in natural speech, and greater clinical symptom burden. Notably, beta abnormalities emerged as distributed latent patterns spanning sensory, motor, and frontotemporal regions. Together, these findings identify diminished event-related beta modulation as a common neural signature linking disrupted multisensory integration, action monitoring, and language organization in schizophrenia. We situate perceptual and expressive impairments within a unified framework of predictive dysfunction and advance a mechanistically grounded account that highlights beta dynamics as a promising target for future mechanistic and translational studies in psychosis. Significance StatementSchizophrenia disrupts both how people perceive the world and how they express their thoughts, yet these symptoms are usually studied separately. Using magnetoencephalography during multisensory and motor tasks, we identify a shared neural mechanism linking these domains: reduced event-related modulation of beta-band (15-30 Hz) activity, a signal implicated in predictive control. Compared to healthy individuals, patients showed diminished beta changes during sensory processing and movement completion, suggesting reduced flexibility in updating internal models. Importantly, this neural pattern covaried with abnormal audiovisual binding, disorganized natural speech, and greater clinical severity. These findings reveal distributed beta modulation as a cross-domain neural marker of predictive dysfunction, offering a unified framework for understanding perceptual and expressive disturbances in schizophrenia.

neuroscience↗

bioRxiv2025

Class IV plant U-box proteins function redundantly to optimize protein accumulation of receptor-like cytoplasmic kinase BIK1

In Arabidopsis thaliana, the receptor-like cytoplasmic kinase BOTRYTIS INDUCED KINASE 1 (BIK1) is a direct substrate of multiple transmembrane immune receptor kinases and plays a crucial role in immune signal transduction. Inactive BIK1 is poly-ubiquitinated and degraded by the 26S proteasome, which is thought to optimize BIK1 levels in naive cells and may protect against inappropriately high immune responses. Here, we provide biochemical and genetic evidence that supports redundant roles between related Plant U-Box (PUB) proteins PUB22, PUB23, PUB24, PUB25, and PUB26 in BIK1 turnover.

plant biology↗

bioRxiv2024

Aberrant expression of CD14 in breast tumor cells is associated with poor outcome

Emerging evidence suggests that cancer cells can mimic features of immune cells during oncogenic transformation to drive disease progression. We assessed the occurrence of immunological markers in breast cancer cells to determine their expression pattern. We initially analyzed 18 immune protein markers (CCR4, CCR6, CCR7, CD11, CD123, CD14, CD16, CD19, CD24, CD25, CD27, CD3, CD38, CD4, CD45, CD56, CD8 and CXCR3) expressed on the surface of 28 breast cancer cell lines using mass spectrometry. CD14 protein expression in tumor cells and its association with clinical outcomes was subsequently evaluated by tissue microarray (TMA) analysis of 346 breast tumors. Single-cell RNA sequencing data from breast cancer tumors and bulk transcriptomic data of breast cancer cell lines were interrogated for molecular signatures associated with CD14 tumor cell expression. Among the markers interrogated, CD14 protein was aberrantly expressed on the surface of 13 out of 15 triple-negative breast cancer (TNBC), one of six hormone receptor positive (HR+), one of five hormone receptors negative (HR-)/Her2+ cell lines. Likewise, RNA expression revealed higher levels of CD14 in TNBC cell lines compared to other subtypes. Tumor tissue microarray analysis revealed elevated levels of CD14 membrane expression predominantly in TNBC and was associated with higher tumor grade and increased incidence of disease recurrence compared to CD14-negative tumors. The CD14-positive subgroup exhibited Nuclear Factor Kappa Beta (NFkB) and TGF-{beta} centric networks at both the protein and Single-cell RNA levels. We have uncovered a novel subset of breast cancers characterized by aberrant surface expression of CD14 associated with aggressive disease. CD14 identifies a subset of breast cancers with poor outcome and is a potential therapeutic target.

cancer biology↗

bioRxiv2024

Conservation of an immune homeostasis module in land plants

Calcium-dependent protein kinases (CDPKs) decode cellular calcium transients and play diverse roles in plant growth and stress responses, including immunity. In Arabidopsis thaliana (At, Arabidopsis thereafter), AtCPK28 contributes to immune homeostasis by phosphorylating subgroup IV plant U-box proteins AtPUB22/24/25/26, which target the key immune receptor-like cytoplasmic kinase (RLCK) AtBIK1 for turnover. While this module is conserved in multiple angiosperms, it is unclear if the role of CPK28 in immune homeostasis is conserved more broadly across land plants. Here, we took an evolutionary comparative approach to understand the role of CPK28. We identified a single CPK28 ortholog in the liverwort Marchantia polymorpha, MpCPK28, which exhibits Ca2+-dependent kinase activity that is inhibited by calmodulin in vitro. We identified the subgroup IV plant U-box protein MpPUB20e as a substrate of MpCPK28. MpPUB20e is able to ubiquitinate MpPBLa, the functional ortholog of AtBIK1. We also provide preliminary evidence that MpPBLa undergoes proteasomal degradation in Marchantia, suggesting that optimization of MpPBLa protein accumulation is conserved across land plants. Interestingly, while loss of CPK28 function in multiple angiosperm species results in enhanced immune signaling, we find that Marchantia Mpcpk28 mutant alleles do not display enhanced immune-triggered production of reactive oxygen species or resistance to two pathogens. However, transgenic expression of MpCPK28 was able to restore function in Arabidopsis cpk28-1 mutants, suggesting latent functional conservation of MpCPK28. Furthermore, while AtCPK28-mediated phosphorylation of Thr95/94 on AtPUB25/26 is known to contribute to their activation, we could not observe a functional role for the equivalent residue Thr122 on MpPUB20e. Taken together, our results suggest that post-translational fine-tuning by CPK28 is likely to have refined the PUB-BIK1 module in the vascular plant lineages.

plant biology↗

bioRxiv2024

Catalytically inactive subgroup VIII receptor-like cytoplasmic kinases regulate the immune-triggered oxidative burst in Arabidopsis thaliana

Protein kinases are key components of multiple cell signaling pathways. Several protein kinases of the receptor-like cytoplasmic kinase (RLCK) family have demonstrated roles in immune and developmental signaling across various plant species, making them a family of interest in the study of phosphorylation-based signal relay. Here, we present our investigation of a subfamily of RLCKs in Arabidopsis thaliana. Specifically, we focus on subgroup VIII RLCKs: MAZ and its paralog CARK6, as well as CARK7 and its paralog CARK9. We found that both MAZ and CARK7 associate with the calcium-dependent protein kinase CPK28 in planta, and furthermore that CPK28 phosphorylates both MAZ and CARK7 on multiple residues in areas that are known to be critical for protein kinase activation. Genetic analysis suggests redundant roles for MAZ and CARK6 as negative regulators of the immune-triggered oxidative burst. We find evidence that supports homo- and hetero-dimerization between CARK7 and MAZ, which may be a general feature of this protein family. Multiple biochemical experiments suggest that neither MAZ nor CARK7 demonstrate catalytic protein kinase activity in vitro. Interestingly, we find that a mutant variant of MAZ incapable of protein kinase activity is able to complement maz-1 mutants, suggesting noncatalytic roles of MAZ in planta. Overall, our study identifies subgroup VIII RLCKs as new players in Arabidopsis immune signaling and highlights the importance of noncatalytic functions of protein kinases.

plant biology↗

bioRxiv2023

Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an early metabolic alteration

BackgroundThe development of diverse spatial profiling technologies has provided an unprecedented insight into molecular mechanisms driving cancer pathogenesis. Here, we conducted the first integrated cross-species assessment of spatial transcriptomics and spatial metabolomics alterations associated with progression of intraductal papillary mucinous neoplasms (IPMN), bona fide cystic precursors of pancreatic ductal adenocarcinoma (PDAC). MethodsMatrix Assisted Laster Desorption/Ionization (MALDI) mass spectrometry (MS)-based spatial imaging and Visium spatial transcriptomics (ST) (10X Genomics) was performed on human resected IPMN tissues (N= 23) as well as pancreata from a mutant Kras;Gnas mouse model of IPMN. Findings were further compared with lipidomic analyses of cystic fluid from 89 patients with histologically confirmed IPMNs, as well as single-cell and bulk transcriptomic data of PDAC and normal tissues. ResultsMALDI-MS analyses of IPMN tissues revealed long-chain hydroxylated sulfatides, particularly the C24:0(OH) and C24:1(OH) species, to be selectively enriched in the IPMN and PDAC neoplastic epithelium. Integrated ST analyses confirmed that the cognate transcripts engaged in sulfatide biosynthesis, including UGT8, Gal3St1, and FA2H, were co-localized with areas of sulfatide enrichment. Lipidomic analyses of cystic fluid identified several sulfatide species, including the C24:0(OH) and C24:1(OH) species, to be significantly elevated in patients with IPMN/PDAC compared to those with low-grade IPMN. Targeting of sulfatide metabolism via the selective galactosylceramide synthase inhibitor, UGT8-IN-1, resulted in ceramide-induced lethal mitophagy and subsequent cancer cell death in vitro, and attenuated tumor growth of mutant Kras;Gnas allografts. Transcript levels of UGT8 and FA2H were also selectively enriched in PDAC transcriptomic datasets compared to non-cancerous areas, and elevated tumoral UGT8 was prognostic for poor overall survival. ConclusionEnhanced sulfatide metabolism is an early metabolic alteration in cystic pre-cancerous lesions of the pancreas that persists through invasive neoplasia. Targeting sulfatide biosynthesis might represent an actionable vulnerability for cancer interception.

cancer biology↗